Runben Biotechnology Co., Ltd. (SHA:603193)
China · Delayed Price · Currency is CNY 23.85
-0.35 (-1.45%)
At close: Feb 6, 2026
Runben Biotechnology Revenue
Runben Biotechnology had revenue of 342.41M CNY in the quarter ending September 30, 2025, with 16.67% growth. This brings the company's revenue in the last twelve months to 1.52B, up 21.75% year-over-year. In the year 2024, Runben Biotechnology had annual revenue of 1.32B with 27.61% growth.
Revenue (ttm)
1.52B
Revenue Growth
+21.75%
P/S Ratio
6.36
Revenue / Employee
1.65M
Employees
921
Market Cap
9.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.32B | 285.22M | 27.61% |
| Dec 31, 2023 | 1.03B | 176.87M | 20.66% |
| Dec 31, 2022 | 856.09M | 273.94M | 47.06% |
| Dec 31, 2021 | 582.15M | 139.32M | 31.46% |
| Dec 31, 2020 | 442.83M | 164.19M | 58.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition